- Home
- MRAM vs ENTA Comparison
MRAM vs ENTA Comparison
Compare MRAM & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRAM
- ENTA
- Stock Information
- Founded
- MRAM 2008
- ENTA 1995
- Country
- MRAM United States
- ENTA United States
- Employees
- MRAM N/A
- ENTA N/A
- Industry
- MRAM Semiconductors
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- MRAM Technology
- ENTA Health Care
- Exchange
- MRAM Nasdaq
- ENTA Nasdaq
- Market Cap
- MRAM 134.5M
- ENTA 109.0M
- IPO Year
- MRAM 2016
- ENTA 2013
- Fundamental
- Price
- MRAM $5.80
- ENTA $5.12
- Analyst Decision
- MRAM Strong Buy
- ENTA Buy
- Analyst Count
- MRAM 2
- ENTA 4
- Target Price
- MRAM $9.00
- ENTA $17.25
- AVG Volume (30 Days)
- MRAM 93.4K
- ENTA 503.4K
- Earning Date
- MRAM 02-26-2025
- ENTA 02-18-2025
- Dividend Yield
- MRAM N/A
- ENTA N/A
- EPS Growth
- MRAM N/A
- ENTA N/A
- EPS
- MRAM 0.07
- ENTA N/A
- Revenue
- MRAM $53,865,000.00
- ENTA $67,635,000.00
- Revenue This Year
- MRAM N/A
- ENTA $8.11
- Revenue Next Year
- MRAM $7.15
- ENTA N/A
- P/E Ratio
- MRAM $80.91
- ENTA N/A
- Revenue Growth
- MRAM N/A
- ENTA N/A
- 52 Week Low
- MRAM $4.89
- ENTA $4.71
- 52 Week High
- MRAM $9.39
- ENTA $17.80
- Technical
- Relative Strength Index (RSI)
- MRAM 35.09
- ENTA 38.07
- Support Level
- MRAM $6.11
- ENTA $4.94
- Resistance Level
- MRAM $6.30
- ENTA $5.31
- Average True Range (ATR)
- MRAM 0.23
- ENTA 0.32
- MACD
- MRAM -0.07
- ENTA 0.11
- Stochastic Oscillator
- MRAM 3.48
- ENTA 39.05
About MRAM Everspin Technologies Inc.
Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA); and Asia-Pacific (APAC).
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.